USE OF ACUTE HEPATITIS SURVEILLANCE TO EVALUATE PROGRAM FOR VIRAL HEPATITIS PREVENTION AND CONTROL Central Asian Program, DIH, EPO, CDC.

Slides:



Advertisements
Similar presentations
“a mechanism for the collection, processing, analysis and transmission of information required for organizing and operating health services, and also for.
Advertisements

“Concepts in evaluation of vaccination programs in low income countries" Jagrati Jani Section for International Health Department of Community Medicine.
Declining HIV Prevalence among young women in Botswana: Results from the 2009 ANC Sentinel Surveillance survey Authors: Yadav Bindeshwar P Anderson Marina.
1 European Region Global Alliance for Vaccines & Immunization Overview on the Implementation Of the Introduction of New / Under-used Vaccines.
Perinatal Hepatitis B Prevention
Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention Epidemiology of HIV Infection through 2012.
Prevention and control of Hepatitis B In Central and Eastern Europe and Newly Independent States WHO/EURO.
Monitoring & Evaluation for Routine Immunization: Data For Action
Measles outbreak investigation & Response Jordan DR MOHAMAD RATIB SUROUR NATIONAL EPI MANAGER INTER-COUNTRY MEETING ON MEASLES AND RUBELLA CONTROL AND.
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
Adult Immunization 2010 Hepatitis B Vaccine Segment
‏Hepatitis B Eliminating Transmission Preventing Disease* John W. Ward, M.D. Division of Viral Hepatitis Centers for Disease Control and Prevention * The.
Dr. Richard B. Munyaneza, MD, Rwanda Ministry of Health.
Session 4: Delivery Hospital as Safety Net Lisa Jacques-Carroll, MSW NCIRD, CDC.
Global Measles and Rubella Management Meeting Progress and Challenges in Bangladesh March, 2011 Geneva, WHO HQ Dr Serguei Diorditsa.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Source: National Notifiable Diseases Surveillance System (NNDSS)
A Valuable Resource: Health Sector as a Beneficiary and Contributor to CRVS Systems.
A Comprehensive Policy framework for the National Immunization Programme Dr Nihal Abeysinghe, [M.B.,B.S., MSc, M.D.] Chief Epidemiologist, Ministry of.
Healthy Kansans living in safe and sustainable environments.
Health Cluster Response Plan CAP 2013 SANA”A, YEMEN October 20 th, 2012.
Epidemiology Tools and Methods Session 2, Part 1.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
Harold S. Margolis, M.D. Division of Viral Hepatitis
Hepatitis B Virus 28.
Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.
Integrated Surveillance for HIV, Viral Hepatitis, and Sexually Transmitted Diseases in Central Asia Region CDC Central Asia Program, DIH, EPO; Division.
Expanded Program of Immunization Dr. Faten M. Rabie.
Application in professional activity of theoretical knowledge and practical skills acquired during residency program Dr. Ion Bîrcă National Center of Public.
USE OF ACUTE HEPATITIS SURVEILLANCE TO EVALUATE PROGRAM FOR VIRAL HEPATITIS PREVENTION AND CONTROL Central Asian Program, DIH, EPO, CDC.
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Overview of Hepatitis B, C, and D Epidemiology in Eastern Europe and the Newly Independent States Michael O. Favorov MD, Ph.D., D.Sc. CDC Central Asia.
*Adjusted for underreporting. Source: National Notifiable Diseases Surveillance System (NNDSS)
STDs among Men who Have Sex with Men (MSM), San Francisco 2007—2010 STD Prevention and Control Services San Francisco Department of Public Health.
Exposure to cyclo-oxygenase-2 inhibitors and risk of cancer: nested case-control studies IAE world Congress Epidemiology 2011 Edinburgh Yana Vinogradova,
Conclusions of the meeting and closing remarks. Chronology 1981Hepatitis B vaccine becomes available 1991World Health Assembly resolution call for the.
SEIEVA Integrated Epidemiological System for Acute Viral Hepatitis Alfonso Mele Catania, November
21/4/2008 Evaluation of control measures 1. 21/4/2008 Evaluation of control measures 2 Family and Community Medicine Department.
WHO Regional Office for Europe Update on WHO GAVI European Regional Working Group and hepatitis B Immunization Viral Hepatitis Prevention Board Meeting.
Olivia Chang, MPH Research and Program Manager Pangaea Global AIDS
Situation overview and Meeting Objectives The Middle East Polio Outbreak Phase II Review.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.
Focus Area 25 Sexually Transmitted Diseases Progress Review July 21, 2004.
Is for Epi Epidemiology basics for non-epidemiologists.
"Epidemiological Features of Rotavirus Infection among children below 5 years old in Jordan, Rationale for Vaccine Introduction,2015" Kareman Juma`ah Al-Zain.
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Sexually Transmitted Disease Prevention.
Diabetes and Obesity Journal Club Carina Signori Endocrinology Fellow
Association between injection of ‘Snow blow’ and HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015.
CENTER FOR PUBLIC HEALTH PRACTICE Public Health Division Center for PH Practice Collette Young, PhD Oregon Public Health Orientation 2016.
| Web: The findings and conclusions in this report are those of the authors and do not necessarily represent the official.
Department of Preventive Medicine Faculty of Public Health University of Debrecen General Practitioners’ Morbidity Sentinel Stations Program (GPMSSP) to.
IPC INFECTION PREVENTION & CONTROL PROGRAM Improving post-exposure prophylaxis (PEP) reporting and documentation: Experiences from Iringa pilot Amal Ally.
Notified AIDS and HIV Infection Cases in the Seychelles: Epidemiological Trends Ministry of Health, SeychellesMinistry of Health, Seychelles –N. E. Udonwa.
Adult Hepatitis A and B Vaccination in Traditional and Non-Traditional Sites, North Carolina Beth Rowe-West, Head Immunization Branch Division of Public.
Where Has All the Pertussis Gone? Pertussis Trends from and the Potential Early Impact of Tdap Vaccination National Immunization Conference Dallas,
Source: National Notifiable Diseases Surveillance System (NNDSS)
Bloodborne viral and sexually transmissible infections in Aboriginal and Torres Strait Islander people: Annual Surveillance Report 2016.
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Bhutan Last updated: September 2016.
Central American Certificate Course: HIV Monitoring and Evaluation for HIV/AIDS Policy and Program Management BZ Unit 2 – Post test CR ES GT NI PA January.
Public Health Response to Zika Virus in California
RISK R isk of Perinatal and Early Childhood Infection
Hepatitis B Vaccination Assessment Adults Aged Years National Health Interview Survey, 2000 Gary L. Euler, DrPH1, Hussain Yusuf, MBBS2, Shannon.
Implementing New ACIP Adult Hepatitis B Vaccine Recommendations Eric E
Bhutan Last updated: July 2018.
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

USE OF ACUTE HEPATITIS SURVEILLANCE TO EVALUATE PROGRAM FOR VIRAL HEPATITIS PREVENTION AND CONTROL Central Asian Program, DIH, EPO, CDC

GNP/capita (USD) Country/Years (estimate for 2002) GNP increase Kazakhstan % Kyrgyzstan % Tajikistan ,80.4% Turkmenistan517552,56.9% Uzbekistan ,33.4% European Bank for Reconstruction and Development. Transition Report Update, May 2002.

Aims: To evaluate parenteral hepatitis risk factors To assess an impact of universal newborn Hepatitis B immunization program

Materials and Methods (1) Study design: matched case control study (1 case + 2 controls matched by age, sex and place of residence) Cases: acute hepatitis B, C and D cases (parenteral hepatitis), Controls: acute hepatitis A cases, N = 214 case-control sets EPI INFO matched case-control analysis followed by conditional logistic regression

Risk Factors (6 months prior to the onset of disease) Blood transfusion Surgery Injections in hospital Injections in polyclinic Blood samples collection in polyclinic Visit to surgeon, dentist, urologist, gynecologist Blood donation Multiple sexual partners STD

Risk Factors of Parenteral Hepatitis (monovariable analisys) Факторы рискаFrequency (N=642) ORConfidence interval СI 0.95 P value Cases Controls Blood transfusion 5.6%0.2%24.0 [3.1; 184.6]<0.001 Injections in hospital 5.6%0.9%7.67.6[2.1; 27.6]<0.001 Injections in policlinic 22.0%7.2%3.53.5[2.1; 5.8]<0.001 Surgeon 7.0%1.6%4.8[1.9; 12.6]<0.001 Multiple sexual partners 4.7%1.4%8.78.7[1.8; 41.9]<0.05

Risk Factors of Parenteral Hepatitis(2) Risk factors βί OR=e Confidence interval СI 0.95 P value Blood transfusion 11.4 [ 1.3; 99.7 ] <0,05 Injections in hospital 3.2 [ 2.0; 5.9 ] <0,001 Injections in policlinic 5.7 [ 1.1; 15.9 ] <0,001 Surgeon 1.1 [ 0.2; 5.4 ] >0,05 Multiple sexual partners 5.2 [ 1.5; 17.6 ] <0,01

Conclusion Risk of parenterally transmitted viral hepatitis remains significant in health facilities. The system of blood and injection safety should be improved The system of health communication and training to improve understanding of natural Hep B transmission mechanisms and prevention measures should be strengthened (+HIV)

Hepatitis B Immunization Program in Kyrgyzstan Introduced in April 1999 High immunization coverage – > 95% 23 cases of acute HB among fully immunized children registered by routine surveillance

Materials and Methods (2) Comparison of acute hepatitis B incidence rates among vaccinated and unvaccinated children born in sentinel sites between 2000 and 2003 Analyses of acute hepatitis B incidence among children under 5 years of age in sentinel sites for the period 2000 to 2003 –Hepatitis B cases: acute hepatitis sentinel surveillance database –Vaccination status of acute hepatitis B cases: primary health facility immunization records –Number of children in age groups and vaccination status of non-infected children: official statistical data of the Ministry of Health

Acute Hepatitis B Cases Among Children Under 4, Sentinel Surveillance, Sentinel sites Number of children under 4 Children born after April 1999 C hildren fully immunized Bishkek 1540 Dzalal-Abad 3392 Naryn 510 Total: 53142

Incidence rates among vaccinated and unvaccinated children, Bishkek, Naryn, Jalalabat, Number of children born in Number of fully vaccinated children Number unvaccinated children672 Number of acute HB cases among vaccinated children 2 Number of acute HB cases among unvaccinated children 12 Incidence rate among vaccinated children2.9 per 100,000 child- years Incidence rate among unvaccinated children760.0 per 100,000 child-years

Acute Hepatitis Incidence Among children under 5, ,4 18,8 7 5, % Morbidity ratio %000 VHB morbidity rateVHB immunization coverage

Conclusions (1) AHSS allows effective MONITORING of immunization program, providing the ability to: –carry out epidemiological investigation of every case of acute viral Hepatitis B –identify and quickly respond to immunization program errors

Conclusions (2) KAHSS provides: the ability to EVALUATE the impact of an immunization program An advocacy tool to support the necessity of sustainable immunization programs

Study Limitations Evaluation of risk factors: –Use of acute hepatitis A cases as controls; –Aggregation of acute hepatitis B, C and D cases into one group of parenteral hepatitis Evaluation of Immunization program: –Use of official statistical data to define the size of target age groups and vaccinated and unvaccinated children

Acknowledgements The Ministry of Health of the Kyrgyz Republic Republican Center for Viral Hepatitis Prevention State Department of Sanitation and Epidemiological Surveillance Republican Center for Immunization